4th Quarter - Amendment

CURE SMA for CURE SMA

Firm
Client
Income
—
Expenses
$35,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 21, 2020 $35,000 Replaced
4th Quarter - Amendment (this page) Jan 30, 2020 $35,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

newborn screening, biomedical research funding, durable medical equipment

LobbyistCovered position, as disclosed
MAYNARD FRIESZ New —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

biomedical research funding, newborn screening appropriations

LobbyistCovered position, as disclosed
MAYNARD FRIESZ New —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.